Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
- Resource Type
- Article
- Source
- The Lancet Gastroenterology & Hepatology; February 2022, Vol. 7 Issue: 2 p118-127, 10p
- Subject
- Language
- ISSN
- 24681253